The Florida Department of Health announced a proposal to amend state regulations so that pharmacists may administer a vaccine against chikungunya, a mosquito-borne virus that has caused 189 reported cases in Florida this year. The rule change would expand the locations where the vaccine could be offered, moving beyond traditional clinics and hospitals to include community pharmacies throughout the state.
Chikungunya infection typically presents with high fever and intense joint pain, symptoms that can be confused with those of dengue or Zika viruses. The illness is transmitted by Aedes mosquitoes, which are also responsible for spreading other arboviruses. While most patients recover, the joint pain can persist for weeks or months, creating a significant burden on individuals and health resources.
Under the proposed rule, pharmacists who complete a state‑approved training program would be authorized to screen patients, provide the vaccine, and record the administration in the state immunization registry. The Department of Health noted that pharmacists are already authorized to give a range of vaccines, including influenza and COVID-19, and that expanding their scope could improve access, especially in underserved areas.
The proposal comes as public health officials continue to monitor the spread of chikungunya across the state. The 189 cases reported so far represent a rise from previous years, prompting concerns about the potential for wider transmission during the upcoming mosquito season. By enabling pharmacy-based vaccination, officials hope to increase coverage quickly and reduce the risk of further outbreaks.
The rule change will be subject to a public comment period, after which the department will decide whether to adopt the amendment. If implemented, pharmacists would begin offering the chikungunya vaccine following the completion of required training and certification, aligning Florida with other states that have broadened pharmacist vaccination authority.